<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01291290</url>
  </required_header>
  <id_info>
    <org_study_id>H-D-2009-002</org_study_id>
    <nct_id>NCT01291290</nct_id>
  </id_info>
  <brief_title>START - Early Thrombocyte Administration to Patients With Ruptured Abdominal Aortic Aneurism</brief_title>
  <acronym>rAAA</acronym>
  <official_title>Thrombocyte Administration Versus no Thrombocytes to Patients With Ruptured Abdominal Aortic Aneurism Before Transport to Hospital With Vascular Surgical Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of platelet infusion prior to transfer
      to a vascular surgical department in patients with a ruptured abdominal aortic aneurism.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality during the first 30days after randomization, and time to death during the 30 days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute myocardial infarction</measure>
    <time_frame>30 days</time_frame>
    <description>Development of AMI during the first 30 days after randomization, and the time to development during the first 30 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative kidney failure</measure>
    <time_frame>30 days</time_frame>
    <description>The need for dialysis during the first 30 days, time to start of dialysis and length.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative pulmonary insufficiency</measure>
    <time_frame>30 days</time_frame>
    <description>Length of respirator treatment in the ICU during the first 30 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in ICU</measure>
    <time_frame>until discharged from ICU</time_frame>
    <description>Length of stay in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in hospital</measure>
    <time_frame>until discharged from hospital</time_frame>
    <description>Until discharged from main surgical department or if transferred to local hospital, when the patient leave local hospital.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">420</enrollment>
  <condition>Ruptured Abdominal Aortic Aneurism</condition>
  <arm_group>
    <arm_group_label>Control treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual transfusion regime to patients with rAAA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thrombocyte</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early thrombocyte administration to patients with rAAA</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet</intervention_name>
    <description>2 portions of platelets (one portion = pooled from 4 donors, 350ml) infused when diagnosed with rAAA and vascular surgeon accepts to receive the patient, infused before transportation.</description>
    <arm_group_label>Thrombocyte</arm_group_label>
    <other_name>Thrombocyte</other_name>
    <other_name>Platelets</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosed with rAAA either by clinical evaluation or CT or UL

        Exclusion Criteria:

          -  formerly randomized in the study

          -  aneurism not ruptured during operation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henning Bay Nielsen, MD</last_name>
    <role>Study Chair</role>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Bech Jørgensen, MD</last_name>
    <phone>25620901</phone>
    <email>starttrial@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>Oesterbro</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Bech Jørgensen, MD</last_name>
      <phone>25620901</phone>
      <email>starttrial@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Bech Jørgensen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2011</study_first_submitted>
  <study_first_submitted_qc>February 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2011</study_first_posted>
  <last_update_submitted>March 13, 2013</last_update_submitted>
  <last_update_submitted_qc>March 13, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Thomas Bech Jorgensen</investigator_full_name>
    <investigator_title>Afdelingslaege</investigator_title>
  </responsible_party>
  <keyword>rAAA</keyword>
  <keyword>Platelets</keyword>
  <keyword>TEG</keyword>
  <keyword>Massive bleeding</keyword>
  <keyword>Coagulopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Aortic Rupture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

